- Home
- GTIM vs PMN Comparison
GTIM vs PMN Comparison
Compare GTIM & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GTIM
- PMN
- Stock Information
- Founded
- GTIM 1987
- PMN 2004
- Country
- GTIM United States
- PMN Canada
- Employees
- GTIM N/A
- PMN N/A
- Industry
- GTIM Restaurants
- PMN Pharmaceuticals and Biotechnology
- Sector
- GTIM Consumer Discretionary
- PMN Health Care
- Exchange
- GTIM Nasdaq
- PMN Nasdaq
- Market Cap
- GTIM 19.6M
- PMN 18.8M
- IPO Year
- GTIM 1990
- PMN N/A
- Fundamental
- Price
- GTIM $1.69
- PMN $0.51
- Analyst Decision
- GTIM
- PMN Strong Buy
- Analyst Count
- GTIM 0
- PMN 2
- Target Price
- GTIM N/A
- PMN $4.50
- AVG Volume (30 Days)
- GTIM 21.6K
- PMN 55.0K
- Earning Date
- GTIM 05-08-2025
- PMN 05-12-2025
- Dividend Yield
- GTIM N/A
- PMN N/A
- EPS Growth
- GTIM 66.31
- PMN N/A
- EPS
- GTIM 0.10
- PMN N/A
- Revenue
- GTIM $144,332,000.00
- PMN N/A
- Revenue This Year
- GTIM N/A
- PMN N/A
- Revenue Next Year
- GTIM N/A
- PMN N/A
- P/E Ratio
- GTIM $19.14
- PMN N/A
- Revenue Growth
- GTIM 4.15
- PMN N/A
- 52 Week Low
- GTIM $1.80
- PMN $0.51
- 52 Week High
- GTIM $3.45
- PMN $2.37
- Technical
- Relative Strength Index (RSI)
- GTIM 34.89
- PMN 37.42
- Support Level
- GTIM $1.82
- PMN $0.48
- Resistance Level
- GTIM $1.90
- PMN $0.59
- Average True Range (ATR)
- GTIM 0.12
- PMN 0.07
- MACD
- GTIM -0.00
- PMN -0.01
- Stochastic Oscillator
- GTIM 0.00
- PMN 14.00
About GTIM Good Times Restaurants Inc.
Good Times Restaurants Inc is engaged in developing, owning, operating, and franchising hamburger-oriented drive-through restaurants. It operates through two segments: Good Times Burgers and Frozen Custard restaurants which operate in the quick-service drive-through dining industry; and Bad Daddy's Burger Bar restaurants which operate in the full-service upscale casual dining industry. The company generates maximum revenue from the Bad Daddy's Burger Bar restaurants segment. Its menu categories include burgers; chicken; frozen custard; slides and drinks.
About PMN ProMIS Neurosciences Inc. (ON)
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.